GAEC1 and colorectal cancer: a study of the relationships between a novel oncogene and clinicopathologic features

Human Pathology

Volumn 41, Issue 7, 2010, Pages 1009-1015

  Gopalan, Vinod ^a   Smith, Robert A ^a   Nassiri, Mohammad R ^b   Yasuda, Koichi ^a   Salajegheh, Ali ^a   Kim, Sang Y ^c   Ho, Yik Hong ^d   Weinstein, Stephen ^a   Tang, Johnny C O ^e   Lam, Alfred K Y ^a  

^a GRIFFITH UNIVERSITY   (Australia)

^b FERDOWSI UNIVERSITY OF MASHHAD   (Iran)

^c Konkuk University School of Medicine   (South Korea)

^d JAMES COOK UNIVERSITY   (Australia)

^e HONG KONG POLYTECHNIC UNIVERSITY   (Hong Kong)

Author keywords

Adenocarcinoma; Adenoma; Colorectum; GAEC1; Gene

Indexed keywords

DNA; PROTEIN GAEC1; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; ASCENDING COLON; CANCER LOCALIZATION; CHILD; CLINICAL FEATURE; COLON ADENOCARCINOMA; COLORECTAL ADENOMA; COLORECTAL CANCER; CONTROLLED STUDY; ESOPHAGUS CANCER; FEMALE; GENE AMPLIFICATION; GENE DELETION; GENE DOSAGE; GENE LOCATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; ONCOGENE; PATHOGENESIS; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SCHOOL CHILD;

ADENOCARCINOMA; ADENOMA; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; COLORECTAL NEOPLASMS; FEMALE; GENE DOSAGE; HUMANS; MALE; MIDDLE AGED; MUCINS; NUCLEAR PROTEINS; YOUNG ADULT;

EID: 77953286962     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2009.11.014     Document Type: Article

References (26)

1. Wienberg R.A. Oncogenes, antioncogenes and the molecular bases of multistep oncogenesis. Cancer Res 49 (1989) 3713-3721
2. Lam A.K., and Ho Y.H. Primary squamous cell carcinoma of the rectum in a patient on immunosuppressive therapy. Pathology 38 (2006) 74-76
3. Weekes J., Lam A., Sebesan S., and Ho Y.H. Irinotecan therapy and molecular targets in colorectal cancer: a systemic review. World J Gastroenterol 15 (2009) 3597-3602
4. Alvarado M.D., Jensen E.H., and Yeatman T.J. The potential role of gene expression in the management of primary and metastatic colorectal cancer. Cancer Control 13 (2006) 27-31
5. Lam A.K., Ong K., Giv M.J., and Ho Y.H. p16 expression in colorectal adenocarcinoma: marker of aggressiveness and morphological types. Pathology 40 (2008) 580-585
6. Lam A.K., Ong K., and Ho Y.H. Aurora kinase expression in colorectal adenocarcinoma: correlations with clinicopathological features, p16 expression, and telomerase activity. Hum Pathol 39 (2008) 599-604
7. Lam A.K., Ong K., and Ho Y.H. hTERT expression in colorectal adenocarcinoma: correlations with p21, p53 expressions and clinicopathological features. Int J Colorectal Dis 23 (2008) 587-594
8. Lam A.K.Y., Ong K., and Ho Y.H. Colorectal mucinous adenocarcinoma: the clinicopathologic features and significance of p16 and p53 Expression. Dis Colon Rectum 49 (2006) 1275-1283
9. Saleh S., Lam A.K., and Ho Y.H. Real-time PCR quantification of human telomerase reverse transcriptase (hTERT) in colorectal cancer. Pathology 40 (2008) 25-30
10. Tang J.C.O., Lam K.Y., Law S., Wong J., and Srivastava G. Detection of genetic alterations in esophageal squamous cell carcinomas and adjacent normal epithelia by comparative DNA fingerprinting using inter-simple sequence repeat PCR. Clin Cancer Res 7 (2001) 1539-1545
11. Law F.B., Chen Y.W., Wong K.Y., et al. Identification of a novel tumor transforming gene GAEC1 at 7q22 which encodes a nuclear protein and is frequently amplified and overexpressed in esophageal squamous cell carcinoma. Oncogene 26 (2007) 5877-5888
12. Choong M.L., Tan L.K., Lo S.L., et al. An integrated approach in the discovery and characterization of a novel nuclear protein over-expressed in liver and pancreatic tumors. FEBS Lett 496 (2001) 109-116
13. Rao P.H., Arias-Pulido H., Lu X.Y., et al. Chromosomal amplifications, 3q gain and deletions of 2q33-q37 are the frequent genetic changes in cervical carcinoma. BMC Cancer 6 (2004) 4-5
14. Nagel S., Leich E., Quentmeier H., et al. Amplification at 7q22 targets cyclin-dependent kinase 6 in T-cell lymphoma. Leukemia 22 (2008) 387-392
15. Suzuki A., Shibata T., Shimada Y., et al. Identification of SMURF1 as a possible target for 7q21.3-22.1 amplification detected in a pancreatic cancer cell line by in-house array-based comparative genomic hybridization. Cancer Sci 99 (2008) 986-994
16. Brody J.R., Hucl T., Gallmeier E., Winter J.M., Kern S.E., and Murphy K.M. Genomic copy number changes affecting the thymidylate synthase (TYMS) gene in cancer: a model for patient classification to aid fluoropyrimidine therapy. Cancer Res 66 (2006) 9369-9373
17. Hamilton S.R., Vogelstein B., Kudo S., Riboli E., Nakamura S., and Hainaut P. In: Hamilton S.R., and Aaltonen L.A. (Eds). Carcinoma of the colon and rectum. WHO classification of tumors: pathology and genetics of tumors of digestive system (2000), IARC Press, Lyon (France) 105-119
18. Cserni G. Nodal staging of colorectal carcinomas and sentinel nodes. J Clin Pathol 56 (2003) 327-335
19. Smith R.A., Lea R.A., Weinstein S.R., and Griffiths L.R. Progesterone, glucocorticoid, but not estrogen receptor mRNA is altered in breast cancer stroma. Cancer Lett 255 (2007) 77-84
20. Livak K.J., and Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25 (2001) 402-408
21. Iacopetta B. Are there two sides to colorectal cancer?. Int J Cancer 101 (2002) 403-408
22. Kapiteijn E., Liefers G.J., Los L.C., et al. Mechanisms of oncogenesis in colon versus rectal cancer. J Pathol 195 (2001) 171-178
23. Campo E., de la Calle-Martin O., Miquel R., et al. Loss of heterozygosity of p53 gene and p53 protein expression in human colorectal carcinomas. Cancer Res 51 (1991) 4436-4442
24. Vanharanta S., Wortham N.C., Langford C., et al. Definition of a minimal region of deletion of chromosome 7 in uterine leiomyomas by tiling-path microarray CGH and mutation analysis of known genes in this region. Genes Chromosomes Cancer 46 (2007) 451-458
25. Ptacek T., Song C., Walker C.L., and Sell S.M. Physical mapping of distinct 7q22 deletions in uterine leiomyoma and analysis of a recently annotated 7q22 candidate gene. Cancer Genet Cytogenet 174 (2007) 116-120
26. Nowell P.C. Chromosomal and molecular clues to tumor progression. Semin Oncol 16 (1989) 116-127